Related Articles While Investors Target New Hedge Funds, MassPRIM Assesses Current Roster James Comtois Premium RA Capital Preps New Biotech SPAC — With an Eye on China’s Risks Stephen Taub II Communities on Global Markets Sponsored by CME Group